Table 5.

Intervention: use of antacids. Characteristics of the studies in dogs.

Reference	Type of Study/Design	Animals (Dogs)	Control/Intervention	Fasting Duration	Procedure
Panti et al., 2009 [12]	randomized, blinded, controlled clinical trial	47, weight 32.7 ± 14.3 kg	no omeprazole/omeprazole 1 mg/kg	>12 h	pelvic limb surgery
Zacuto et al., 2012 [40]	prospective, randomized, blinded, placebo-controlled study	61, age 4.9 ± 3.4 years, weight 25.0 ± 12.9 kg	saline/esomeprazole 1 mg/kg or esomeprazole 1 mg/kg and cisapride 1 mg/kg	>12 h	orthopaedic surgery
Lotti et al., 2021 [39]	prospective, randomised, blinded, clinical trial	55, age 5–60 months, weight 21 ± 6.9 kg	no omeprazole/omeprazole 1 mg/kg or omeprazole two doses of 1 mg/kg each	>12 h	ovariectomy